Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.74 USD | -0.79% | -8.18% | -0.69% |
08/05 | Earnings Flash (SUPN) SUPERNUS PHARMACEUTICALS Reports Q1 Revenue $143.6M, vs. Street Est of $145.8M | MT |
08/05 | Transcript : Supernus Pharmaceuticals, Inc., Q1 2024 Earnings Call, May 08, 2024 |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.69% | 158Cr | |
+11.98% | 908.31Cr | |
-12.85% | 506.36Cr | |
+54.35% | 485.49Cr | |
+1.60% | 385.2Cr | |
+15.11% | 237.15Cr | |
-20.85% | 236.42Cr | |
+24.62% | 226.57Cr | |
-29.25% | 222.12Cr | |
-0.50% | 164.41Cr |
- Stock Market
- Equities
- SUPN Stock
- News Supernus Pharmaceuticals, Inc.
- Supernus Pharmaceuticals : Piper Sandler Adjusts Supernus Pharmaceuticals PT to $35 From $30, Maintains Overweight Rating